ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

intravenous immunoglobulin · ProMetic Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%, covering 2021-08-20 to 2021-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10% [Phase 3]

See pricing